)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Knight Therapeutics (GUD) investor relations material
Knight Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Achieved record-high adjusted revenues of CAD 319 million for the nine months ended September 30, 2025, and record-high quarterly revenues of $121.5M in Q3, up 32%–34% year-over-year, driven by Paladin and Sumitomo transactions and organic growth in key promoted products.
Adjusted EBITDA reached approximately CAD 49 million for the nine months and $21.0M for Q3, a 56% increase year-over-year, with per-share EBITDA up 62%.
Net loss of CAD 4.6 million ($3.8M) in Q3, mainly due to mark-to-market revaluations and higher operating expenses.
Cash inflow from operations was CAD 10 million ($10.2M) for Q3, despite an investment in working capital.
Expanded oncology portfolio and launched three new products in multiple countries.
Financial highlights
Q3 2025 revenues reached CAD 122.6 million ($121.5M), up 34% (32%) year-over-year; constant currency revenue growth was 31%.
Adjusted gross margin rose to CAD 59.9 million (49% of adjusted revenues), up from 47% in Q3 2024; gross margin was $55.8M (46% of revenues).
Adjusted EBITDA for Q3 2025 was CAD 21 million ($21.0M), a 56% increase year-over-year; Adjusted EBITDA per share was CAD 0.21, up 62%.
Net loss of CAD 4.6 million ($3.8M) in Q3, mainly due to mark-to-market revaluations and higher expenses.
Cash, cash equivalents, and marketable securities: $95.6M as of September 30, 2025.
Outlook and guidance
Fiscal 2025 revenue guidance increased to CAD 430–440 million ($430–$440M), with Adjusted EBITDA expected at 13.5%–14.5% of revenues.
Guidance assumes no material adjustment from hyperinflation accounting in Argentina and no major supply disruptions or new generic competition.
Strong performance of promoted products and successful execution of Pan-American ex-U.S. strategy cited as drivers.
How does broad geographic reach enhance deal flow?
What is the commercial impact of regulatory delays?
How will new product investments impact SG&A?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Knight Therapeutics earnings date
Q4 202519 Mar, 2026
Next Knight Therapeutics earnings date
Q4 202519 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Knight Therapeutics Inc is a Canadian specialty pharmaceutical company that acquires, licenses, and commercializes prescription medicines for the Canadian and Latin American markets. The company focuses on late-stage or commercial products across therapeutic areas such as oncology, infectious diseases, and ophthalmology. Knight Therapeutics Inc is headquartered in Montreal, Canada, and its shares are listed on the TSX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage